Press releases

IDC MarketScape Names Medidata a Leader Based on Evaluation of Vendors Offering Solutions for Risk-Based Monitoring of Life Sciences R&D Activities

Medidata has been nominated as a Leader in the “Worldwide Life Science R&D Risk-Based Monitoring Solutions 2022 Vendor Assessment (document code US48061722)” of IDC MarketScape.

For the purposes of this assessment, IDC carefully considered Medidata's comprehensive Risk-Based Quality Management (RBQM) capabilities including Medidata Detect, which enables clinical operations teams to proactively monitor and mitigate risk to patient integrity. data and patient safety.

Medidata Detect

Medidata Detect is a comprehensive risk detection and data management platform that empowers cross-functional teams to identify, document, monitor and mitigate risks to data integrity and patient safety. Tracking users have access to role-based workflows and tasks supported by automated actionable insights, visualizations, and real-time data for better planning and greater efficiency.

As with all Medidata solutions, RBQM customers are supported by the Medidata Professional Services team – consisting of highly regarded experts with extensive clinical trial expertise – who support fast customer enablement and implementation, process improvements, change management and business transformation as well as playing a crucial role in maximizing ROI.

IDC MarketScape

The IDC MarketScape vendor rating model is designed to provide insight into the competitive ability of information and communications technology (ICT) vendors in a given market. The research methodology uses the rigorous assignment of scores based on both qualitative and quantitative criteria that allow the creation of a single graphical illustration of each vendor's position in the market itself. IDC MarketScape presents a clear framework in which you can meaningfully compare the current and future product and service offerings, capabilities and strategies, and drivers of market success of vendors in the IT and telecommunications industries. The framework also provides technology buyers with a 360-degree assessment of the strengths and weaknesses of current and prospective vendors.

Medidata is a subsidiary of Dassault Systèmes, which with its 3DEXPERIENCE platform is positioned to lead the digital transformation of life sciences in the era of personalized medicine through the first comprehensive science and business platform, from research to commercialization.

Innovation newsletter
Don't miss the most important news on innovation. Sign up to receive them by email.

Meditate

The company is leading the digital transformation of life sciences by providing hope to millions of patients. Medidata helps generate the evidence and actionable data that enables pharmaceutical, biotechnology, medical device and diagnostics companies to accelerate value creation, minimize risk and optimize outcomes. More than one million registered users – across more than 2.000 customers and partners – access the world's most trusted platform for clinical development, commercial operations and real-world data. Medidata, an affiliate of Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA), is headquartered in New York City with offices around the world to serve customer needs.

Dassault Systèmes

Dassault Systèmes, the “3DEXPERIENCE Company,” is a catalyst for the progress of humanity. We offer companies and individual entrepreneurs collaborative 3D virtual environments to imagine sustainable innovations. By creating virtual twins of the real world experiences through our applications and the 3DEXPERIENCE platform, our customers push the boundaries of innovation, learning and manufacturing to build a more sustainable world for patients, citizens and consumers. Dassault Systèmes brings value to more than 300.000 customers regardless of their size, across all industries, in more than 140 countries around the world.

3DEXPERIENCE, the Compass icon, the 3DS logo, CATIA, BIOVIA, GEOVIA, SOLIDWORKS, 3DVIA, ENOVIA, NETVIBES, MEDIDATA, CENTRIC PLM, 3DEXCITE, SIMULIA, DELMIA and IFWE are trademarks or registered trademarks of Dassault Systèmes, a “société européenne ” French (Versailles Commercial Register No. B 322 306 440), or its subsidiaries in the United States and/or other countries.

BlogInnovazione.it

Innovation newsletter
Don't miss the most important news on innovation. Sign up to receive them by email.

Latest Articles

Innovative intervention in Augmented Reality, with an Apple viewer at the Catania Polyclinic

An ophthalmoplasty operation using the Apple Vision Pro commercial viewer was performed at the Catania Polyclinic…

May 3, 2024

The Benefits of Coloring Pages for Children - a world of magic for all ages

Developing fine motor skills through coloring prepares children for more complex skills like writing. To color…

May 2, 2024

The Future is Here: How the Shipping Industry is Revolutionizing the Global Economy

The naval sector is a true global economic power, which has navigated towards a 150 billion market...

May 1, 2024

Publishers and OpenAI sign agreements to regulate the flow of information processed by Artificial Intelligence

Last Monday, the Financial Times announced a deal with OpenAI. FT licenses its world-class journalism…

April 30 2024